Effects of angiotensin II on transient receptor potential melastatin 7 channel function in cardiac fibroblasts

Zhou,Yanli; Yi,Xin; Wang,Teng; Li,Mingjiang

doi:10.3892/etm.2015.2362

Effects of angiotensin II on transient receptor potential melastatin 7 channel function in cardiac fibroblasts

Authors:
- Yanli Zhou
- Xin Yi
- Teng Wang
- Mingjiang Li
View Affiliations

Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Gladstone Institute of Cardiovascular Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: March 16, 2015 https://doi.org/10.3892/etm.2015.2362
Pages: 2008-2012

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the electrophysiological properties of transient receptor potential melastatin 7 (TRPM7) channels in the cell membranes of cardiac fibroblasts (CFs). CFs obtained from Sprague‑Dawley rats were treated with six different concentrations of angiotensin (Ang) II for 12 h. The optimum concentration of Ang II for inducing fibrosis was selected by measuring collagen protein expression levels at each concentration. The optimum concentration of Ang II was then used to treat the CFs at five different time‑points, and the TRPM7 current across the CF membranes was recorded along with the collagen protein levels in each group. The optimum Ang II concentration for inducing fibrosis was found to be 1 nmol/l; when it was administered to CFs at 0, 6, 12, 24 and 48 h, the protein expression levels of TRPM7 and collagen III initially increased, reaching maximum levels at 12 h, and then decreased. This result positively correlated with the TRPM7 current levels on either side of the CF membranes: The TRPM7 current under the effect of the optimal Ang II concentration for inducing fibrosis was initially increased and then later decreased. This is one of the key mechanisms by which Ang II mediates the proliferation and apoptosis of CFs. This knowledge may be used to identify treatments for the prevention of cardiac fibrosis.

View Figures

View References

1	Brown RD, Ambler SK, Mitchell MD and Long CS: The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol. 45:657–687. 2005. View Article : Google Scholar : PubMed/NCBI
2	Camelliti P, Borg TK and Kohl P: Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res. 65:40–51. 2005. View Article : Google Scholar : PubMed/NCBI
3	Pawlinski R, Fernandes A, Kehrle B, et al: Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci USA. 99:15333–15338. 2002. View Article : Google Scholar : PubMed/NCBI
4	Jiang J, Li M and Yue L: Potentiation of TRPM7 inward currents by protons. J Gen Physiol. 126:137–150. 2005. View Article : Google Scholar : PubMed/NCBI
5	Li M, Jiang J and Yue L: Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol. 127:525–537. 2006. View Article : Google Scholar : PubMed/NCBI
6	Zhang YH, Sun HY, Chen KH, Du XL, Liu B, Cheng LC, Li X, Jin MW and Li GR: Evidence for functional expression of TRPM7 channels in human atrial myocytes. Basic Res Cardiol. 107:2822012. View Article : Google Scholar : PubMed/NCBI
7	González A, López B and Díez J: Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system. Med Clin North Am. 88:83–97. 2004. View Article : Google Scholar : PubMed/NCBI
8	Olson ER, Shamhart PE, Naugle JE and Meszaros JG: Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension. 51:704–711. 2008. View Article : Google Scholar : PubMed/NCBI
9	Manabe I, Shindo T and Nagai R: Gene expression in fibroblasts and fibrosis: Involvement in cardiac hypertrophy. Circ Res. 91:1103–1113. 2002. View Article : Google Scholar : PubMed/NCBI
10	Runnels LW, Yue L and Clapham DE: The TRPM7 channel is inactivated by PIP (2) hydrolysis. Nat Cell Biol. 4:329–336. 2002.PubMed/NCBI
11	Jiang J, Li M and Yue L: Potentiation of TRPM7 inward currents by protons. J Gen Physiol. 126:137–150. 2005. View Article : Google Scholar : PubMed/NCBI
12	Baldoli E, Castiglioni S and Maier JA: Regulation and function of TRPM7 in human endothelial cells: TRPM7 as a potential novel regulator of endothelial function. PLoS One. 8:e598912013. View Article : Google Scholar : PubMed/NCBI
13	Chen YF, Chen YT, Chiu WT and Shen MR: Remodeling of calcium signaling in tumor progression. J Biomed Sci. 20:232013. View Article : Google Scholar : PubMed/NCBI
14	Simon F, Varela D and Cabello-Verrugio C: Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell Signal. 25:1614–1624. 2013. View Article : Google Scholar : PubMed/NCBI
15	Park HS, Hong C, Kim BJ and So I: The pathophysiologic roles of TRPM7 channel. Korean J Physiol Pharmacol. 18:15–23. 2014. View Article : Google Scholar : PubMed/NCBI
16	Yue Z, Zhang Y, Xie J, Jiang J and Yue L: Transient receptor potential (TRP) channels and cardiac fibrosis. Curr Top Med Chem. 13:270–282. 2013. View Article : Google Scholar : PubMed/NCBI
17	Yi X, Li M, Ma L, et al: Relationship of CTGF, HGF and atrial fibrosis in rheumatic heart disease patients with atrial fibrillation. Wuhan Da Xue Xue Bao. Yi Xue Ban. 33:824–828. 2012.[(In Chinese)].
18	Li M, Yi X, Ma L, et al: Relationship of TRPM7 and atrial fibrosis in rheumatic heart disease patients with atrial fibrillation. Wuhan Da Xue Xue Bao. Yi Xue Ban. 33:875–878. 2012.[(In Chinese)].
19	Yi X, Li X, Zhou Y, et al: Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med. 34:381–390. 2014.PubMed/NCBI
20	Kinoshita T, Ishikawa Y, Arita M, et al: Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor. Cardiovasc Pathol. 23:92–100. 2014. View Article : Google Scholar : PubMed/NCBI